Disulfidptosis-Driven Immune-Activated Multimodal Therapy for Glioblastoma with Systemic Safety Control

Meng Zhang, Chenteng Lin, Khishigjargal Ganbat, Wei Meng, Heemin Kang, Wenjia Gao, Hongyuan Li, Guangwei Jiang, Sharon Prince, Cyrille Boyer, Xinjun Wang, Yi Wang, Rongqin Huang

Open source

DOI: 10.1021/acsnano.5c20124
Published: 2026-10-24
Container: ACS Nano
Publisher: American Chemical Society (ACS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acsnano.5c20124,
  title = {Disulfidptosis-Driven
Immune-Activated Multimodal
Therapy for Glioblastoma with Systemic Safety Control},
  author = {Meng Zhang and Chenteng Lin and Khishigjargal Ganbat and Wei Meng and Heemin Kang and Wenjia Gao and Hongyuan Li and Guangwei Jiang and Sharon Prince and Cyrille Boyer and Xinjun Wang and Yi Wang and Rongqin Huang},
  year = {2026},
  journal = {ACS Nano},
  doi = {10.1021/acsnano.5c20124},
  url = {https://doi.org/10.1021/acsnano.5c20124}
}

RIS

TY  - JOUR
TI  - Disulfidptosis-Driven
Immune-Activated Multimodal
Therapy for Glioblastoma with Systemic Safety Control
AU  - Meng Zhang
AU  - Chenteng Lin
AU  - Khishigjargal Ganbat
AU  - Wei Meng
AU  - Heemin Kang
AU  - Wenjia Gao
AU  - Hongyuan Li
AU  - Guangwei Jiang
AU  - Sharon Prince
AU  - Cyrille Boyer
AU  - Xinjun Wang
AU  - Yi Wang
AU  - Rongqin Huang
PY  - 2026
JO  - ACS Nano
DO  - 10.1021/acsnano.5c20124
UR  - https://doi.org/10.1021/acsnano.5c20124
ER  -

APA

Zhang, M., Lin, C., Ganbat, K., Meng, W., Kang, H., Gao, W., Li, H., Jiang, G., Prince, S., Boyer, C., Wang, X., Wang, Y., & Huang, R. (2026). Disulfidptosis-Driven Immune-Activated Multimodal Therapy for Glioblastoma with Systemic Safety Control. ACS Nano. https://doi.org/10.1021/acsnano.5c20124

Source records

crossref · retrieved 2026-11-11T03:21:09.287Z